Pediatric Drugs

, Volume 9, Issue 5, pp 283–288 | Cite as

Current Issues in Pediatric Medication Adherence

  • Doreen Matsui
Current Opinion


With the recent emphasis on investigating the efficacy of medication in children, it is also important to assess what determines whether pediatric patients do or do not take their medication. In general, children are no better at adhering to drug therapy than older individuals. Dealing with medication nonadherence is essential given its association with a failure to achieve the desired treatment goal. In addition to the many factors that influence adherence in adults, there are some unique challenges faced in the pediatric age group including the role of family (and its dysfunction), the changes of adolescence, and the lack of appropriate drug formulations.

Intervention strategies to improve adherence include behavioral and educational strategies. Although there is no consensus as to what is the best approach to promote adherence with therapy, attention should be given to determining what barriers exist and trying to overcome them by involving children and their parents in the treatment planning process. If possible, the medication regimen, taking into account the frequency and timing of administration, should be tailored to the child and family’s lifestyle and daily routine. Consideration should be given to the palatability and formulations of medications prescribed for young children. The use of simplified regimens of better tasting medications and age-appropriate delivery mechanisms may enhance the ability of pediatric patients to adhere to their drug therapy.


Medication Adherence Budesonide Familial Hypercholesterolemia Parental Supervision Concerta 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



No sources of funding were used to assist in the preparation of this review. The author has no conflicts of interest that are directly relevant to the content of this review.


  1. 1.
    Tebbi CK. Treatment compliance in childhood and adolescence. Cancer 1993; 71: 3441–9PubMedCrossRefGoogle Scholar
  2. 2.
    Bonaccorso S. What information do patients need about medicines? Perspectives from the pharmaceutical industry. BMJ 2003; 327: 863–4PubMedCrossRefGoogle Scholar
  3. 3.
    Winnick S, Lucas DO, Hartman AL, et al. How do you improve compliance? Pediatrics 2005; 115: e718–24PubMedCrossRefGoogle Scholar
  4. 4.
    Burkhart PV, Dunbar-Jacob J. Adherence research in the pediatric and adolescent populations: a decade in review. In: Hayman LL, Mahon MM, Turner JR, editors. Chronic illness in children: an evidence-based approach. New York: Springer Publishing Company, Inc., 2002: 199–229Google Scholar
  5. 5.
    Tilson HH. Adherence or compliance? Changes in terminology. Ann Pharmacother 2004; 38: 161–2PubMedCrossRefGoogle Scholar
  6. 6.
    World Health Organization. Adherence to long-term therapies: evidence for action [online]. Available from URL: [Accessed 2006 Nov 13]
  7. 7.
    Urquhart J. How much compliance is enough? Pharm Res 1996; 13: 10–1PubMedCrossRefGoogle Scholar
  8. 8.
    Ellis S, Shumaker S, Sieber W, et al. Adherence to pharmacological interventions: current trends and future directions. Control Clin Trials 2000; 21: 218S–25SPubMedCrossRefGoogle Scholar
  9. 9.
    Rudd P, Ahmed S, Zachary V, et al. Compliance with medication timing: implications from a medication trial for drug development and clinical practice. J Clin Res Pharmacoepidemiol 1992; 6: 15–27Google Scholar
  10. 10.
    Dusing R, Lottermoser K, Mengden T. Compliance with drug therapy: new answers to an old question. Nephrol Dial Transplant 2001; 16: 1317–21PubMedCrossRefGoogle Scholar
  11. 11.
    DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002; 40: 794–811PubMedCrossRefGoogle Scholar
  12. 12.
    Bauman LJ, Wright E, Leickly FE, et al. Relationship of adherence to pediatric asthma morbidity among inner-city children. Pediatrics 2002; 110: e6PubMedCrossRefGoogle Scholar
  13. 13.
    Ordonez GA, Phelan PD, Olinsky A, et al. Preventable factors in hospital admissions for asthma. Arch Dis Child 1998; 78: 143–7PubMedCrossRefGoogle Scholar
  14. 14.
    Milgrom H, Bender B, Ackerson L, et al. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98: 1051–7PubMedCrossRefGoogle Scholar
  15. 15.
    Stoloff SW. Improving adherence to asthma therapy: what physicians can do. Am Fam Physician 2000; 61(8): 2328, 2330, 2337PubMedGoogle Scholar
  16. 16.
    Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27: 1218–24PubMedCrossRefGoogle Scholar
  17. 17.
    Festa RS, Tamaroff MH, Chasalow F, et al. Therapeutic adherence to oral medication regimens by adolescents with cancer: I. Laboratory assessment. J Pediatr 1992; 120: 807–11PubMedCrossRefGoogle Scholar
  18. 18.
    de Oliveira BM, Viana MB, Zani CL, et al. Clinical and laboratory evaluation of compliance in acute lymphoblastic leukaemia. Arch Dis Child 2004; 89: 785–8PubMedCrossRefGoogle Scholar
  19. 19.
    Lilleyman JS, Lennard L. Non-compliance with oral chemotherapy in childhood leukaemia. BMJ 1996; 313: 1219–20PubMedCrossRefGoogle Scholar
  20. 20.
    Shaw RJ, Palmer L, Blasey C, et al. A typology of non-adherence in pediatric renal transplant recipients. Pediatr Transplant 2003; 7: 489–93PubMedCrossRefGoogle Scholar
  21. 21.
    Meyers KEC, Weiland H, Thomson PD. Paediatric renal transplantation non-compliance. Pediatr Nephrol 1995; 9: 189–92PubMedCrossRefGoogle Scholar
  22. 22.
    Korsch BM, Fine RN, Negrete VF. Noncompliance in children with renal transplants. Pediatrics 1978; 61: 872–6PubMedGoogle Scholar
  23. 23.
    Shemesh E, Shneider BL, Savitzky JK, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics 2004; 113: 825–32PubMedCrossRefGoogle Scholar
  24. 24.
    Ringewald JM, Gidding SS, Crawford SE, et al. Nonadherence is associated with late rejection in pediatric heart transplant recipients. J Pediatr 2001; 139: 75–8PubMedCrossRefGoogle Scholar
  25. 25.
    Gibbs DM, Goodall RL, Giacomet V, et al. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J 2003; 22: 56–62CrossRefGoogle Scholar
  26. 26.
    Farley J, Hines S, Musk A, et al. Assessment of adherence to antiviral therapy in HIV-infected children using the medication event monitoring system, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr 2003; 33: 211–8PubMedCrossRefGoogle Scholar
  27. 27.
    Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006; 333(7557): 15PubMedCrossRefGoogle Scholar
  28. 28.
    Easton LK, Parsons BJ, Starr M, et al. The incidence of drug-related problems as a cause of hospital admissions in children. Med J Aust 1998; 169: 356–9PubMedGoogle Scholar
  29. 29.
    Quittner AL, Espelage DL, Levers-Landis C, et al. Measuring adherence to medical treatments in childhood chronic illness: considering multiple methods and sources of information. J Clin Psychol Med Settings 2000; 7: 41–54CrossRefGoogle Scholar
  30. 30.
    Matsui DM. Drug compliance in pediatrics clinical and research issues. Pediatr Clin North Am 1997; 44: 1–14PubMedCrossRefGoogle Scholar
  31. 31.
    Kruse W. Patient compliance with drug treatment: new perspectives on an old problem. Clin Investig 1992; 70: 163–6PubMedCrossRefGoogle Scholar
  32. 32.
    Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150: 377–8CrossRefGoogle Scholar
  33. 33.
    Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261: 3273–7PubMedCrossRefGoogle Scholar
  34. 34.
    Berkovitch M, Papadouris D, Shaw D, et al. Trying to improve compliance with prophylactic penicillin therapy in children with sickle cell disease. Br J Clin Pharamcol 1998; 45: 605–7CrossRefGoogle Scholar
  35. 35.
    Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23: 1296–310PubMedCrossRefGoogle Scholar
  36. 36.
    Richter A, Anton SF, Koch P, et al. The impact of reducing dose frequency on health outcomes. Clin Ther 2003; 25: 2307–35PubMedCrossRefGoogle Scholar
  37. 37.
    Mattar ME, Markello J, Yaffe SJ. Pharmaceutic factors affecting pediatric compliance. Pediatrics 1975; 55: 101–8PubMedGoogle Scholar
  38. 38.
    Mattar ME, Markello J, Yaffe SJ. Inadequacies in the pharmacologic management of ambulatory children. J Pediatr 1975; 87: 137–41PubMedCrossRefGoogle Scholar
  39. 39.
    Thatcher Shope J. Medication compliance. Pediatr Clin North Am 1981; 28: 5–21Google Scholar
  40. 40.
    Bender BG, Bender SE. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin North Am 2005; 25: 107–30PubMedCrossRefGoogle Scholar
  41. 41.
    Gau SSF, Shen H, Chou M, et al. Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol 2006; 16: 286–97PubMedCrossRefGoogle Scholar
  42. 42.
    Mackner LM, Crandall WV. Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 1006–12PubMedCrossRefGoogle Scholar
  43. 43.
    Staples B, Bravender T. Drug compliance in adolescents assessing and managing modifiable risk factors. Pediatr Drugs 2002; 4: 503–13Google Scholar
  44. 44.
    Litt IF, Cuskey WR. Compliance with medical regimens during adolescence. Pediatr Clin North Am 1980; 27: 3–15PubMedGoogle Scholar
  45. 45.
    Morris AD, Boyle DIR, McMahon AD, et al. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet 1997; 350: 1505–10PubMedCrossRefGoogle Scholar
  46. 46.
    Lancaster D, Lennard L, Lilleyman JS. Profile of non-compliance in lymphoblastic leukaemia. Arch Dis Child 1997; 76: 365–6PubMedCrossRefGoogle Scholar
  47. 47.
    Tebbi CK, Cummings KM, Zevon MA, et al. Compliance of pediatric and adolescent cancer patients. Cancer 1986; 58: 1179–84PubMedCrossRefGoogle Scholar
  48. 48.
    Smith BA, Shuchman M. Problem of nonadherence in chronically ill adolescents: strategies for assessment and intervention. Curr Opin Pediatr 2005; 17: 613–8PubMedCrossRefGoogle Scholar
  49. 49.
    Rosina R, Crisp J, Steinbeck K. Treatment adherence of youth and young adults with and without a chronic illness. Nurs Health Sci 2003; 5: 139–47PubMedCrossRefGoogle Scholar
  50. 50.
    Feinstein S, Keich R, Becker-Cohen R, et al. Is noncompliance among adolescent renal transplant recipients inevitable? Pediatrics 2005; 115: 969–73PubMedCrossRefGoogle Scholar
  51. 51.
    Ramgoolam A, Steele R. Formulations of antibiotics for children in primary care effects on compliance and efficacy. Pediatr Drugs 2002; 4: 323–33Google Scholar
  52. 52.
    Goode M, McMaugh A, Crisp J, et al. Adherence issues in children and adolescents receiving highly active antiretroviral therapy. AIDS Care 2003; 15: 403–8PubMedCrossRefGoogle Scholar
  53. 53.
    Tucker CM, Fennell RS, Pederson T, et al. Associations with medication adherence among ethnically different pediatric patients with renal transplants. Pediatr Nephrol 2002; 17: 251–6PubMedCrossRefGoogle Scholar
  54. 54.
    Dawson A, Newell R. The extent of parental compliance with timing of administration of their children’s antibiotics. J Adv Nurs 1994; 20: 483–90PubMedCrossRefGoogle Scholar
  55. 55.
    Gibson NA, Ferguson AE, Aitchison TC, et al. Compliance with inhaled asthma medication in preschool children. Thorax 1995; 50: 1274–9PubMedCrossRefGoogle Scholar
  56. 56.
    Lau RCW, Matsui D, Greenberg M, et al. Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia. Med Pediatr Oncol 1998; 30: 85–90PubMedCrossRefGoogle Scholar
  57. 57.
    Blowey DL, Herbert D, Arbus GS, et al. Compliance with cyclosporine in adolescent renal transplant recipients. Pediatr Nephrol 1997; 11: 547–51PubMedCrossRefGoogle Scholar
  58. 58.
    Jonasson G, Carlsen K, Mowinckel P. Asthma drug adherence in a long term clinical trial. Arch Dis Child 2000; 83: 330–3PubMedCrossRefGoogle Scholar
  59. 59.
    Moncica I, Oh PI, ul Qamar I, et al. A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension. Arch Dis Child 1995; 73: 154–6PubMedCrossRefGoogle Scholar
  60. 60.
    MacDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions scientific review. JAMA 2002; 288: 2868–79CrossRefGoogle Scholar
  61. 61.
    Costello I, Wong ICK, Nunn AJ. A literature review to identify interventions to improve the use of medicines in children. Child Care Health Dev 2004; 30: 647–65PubMedCrossRefGoogle Scholar
  62. 62.
    Nevins TE. “Why do they do that?” The compliance conundrum. Pediatr Nephrol 2005; 20: 845–8PubMedCrossRefGoogle Scholar
  63. 63.
    DiMatteo MR. The role of effective communication with children and their families in fostering adherence to pediatric regimens. Patient Educ Couns 2004; 55: 339–44PubMedCrossRefGoogle Scholar
  64. 64.
    Bender BG. Overcoming barriers to nonadherence in asthma treatment. J Allergy Clin Immunol 2002; 109: S554–9PubMedCrossRefGoogle Scholar
  65. 65.
    McCrindle BW, O’Neill MB, Cullen-Dean G, et al. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. J Pediatr 1997; 130: 266–73PubMedCrossRefGoogle Scholar
  66. 66.
    Nunn T, Williams J. Formulation of medicines for children. Br J Clin Pharmacol 2005; 59: 674–6PubMedCrossRefGoogle Scholar
  67. 67.
    Tuleu C. An overview of paediatric drug delivery. Drug Deliv Rep 2005 Autumn/Winter [online]. Available from URL: [Accessed 2007 Oct 8]Google Scholar
  68. 68.
    Anbar RD. You don’t like the taste of your medication? So change the taste! Clin Pediatr 2002; 41: 197–8CrossRefGoogle Scholar
  69. 69.
    Sawyer SM, Aroni RA. Sticky issue of adherence. J Pediatr Child Health 2003; 39: 2–5CrossRefGoogle Scholar
  70. 70.
    Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med 2004; 164: 722–32PubMedCrossRefGoogle Scholar
  71. 71.
    Swanson J. Compliance with stimulants for attention-deficit/hyperactivity disorder issues and approaches for improvement. CNS Drugs 2003; 17: 117–31PubMedCrossRefGoogle Scholar
  72. 72.
    Boulet LP. Once-daily inhaled corticosteroids for the treatment of asthma. Curr Opin Pulm Med 2003; 10: 15–21CrossRefGoogle Scholar
  73. 73.
    Boissel J, Nony P. Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor compliance. Clin Pharmacokinet 2002; 41: 1–6PubMedCrossRefGoogle Scholar
  74. 74.
    Urquhart J. Patient non-compliance with drug regimens: measurement, clinic correlates, economic impact. Eur Heart J 1996; 17Suppl. A: 8–15PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2007

Authors and Affiliations

  • Doreen Matsui
    • 1
  1. 1.Department of PaediatricsChildren’s Hospital of Western OntarioLondonCanada

Personalised recommendations